Accelerating the Diagnosis of Genetic Repeat Expansion (GRE) Diseases
3X Genetics seeks to improve lives by accelerating the diagnosis of GRE diseases, which are common and often misdiagnosed. There are 69 known GREs, including Myotonic Dystrophy, Fuchs Endothelial Corneal Dystrophy (FECD), Friedreich’s Ataxia (FA), Huntington’s Disease, Fragile X, and Spinocerebellar Ataxias (SCAs). The good news is that therapeutics are emerging and 3X Genetics is developing a test platform to accurately diagnose GRE diseases at a low cost.
We Exist to Support Patients and Their Families (Our Clients)
Diagnostic Services
Available Soon: Our initial service offers diagnostic testing, monitoring and predictive health guidance for Myotonic Dystrophy (DM1). After launch, 3X Genetics plans to quickly offer comparable services for additional GRE diseases, including Fuchs Endothelial Corneal Dystrophy (FECD), Friedreich’s Ataxia (FA), Fragile X Syndrome (FXS), Huntington’s Disease and spinocerebellar ataxias (SCAs).
How it Works
Contact a 3X Genetics Medical Professional to place an order. Receive a test kit at your home. Provide a saliva sample. Ship the sample in a pre-paid box to 3X Genetic’s CLIA-certified genetic testing lab. In less than 8 weeks review test results. Test results that indicate the need for further testing, or the definitive presence of a GRE disease, will be delivered by 3X Genetic’s Genetic Counsellor.
Data Privacy
3X Genetics protects patient privacy. All test results are owned by our clients or their designated medical representative. This means all patient data is encrypted and client controlled. Further, if applicable, any information shared with a test sponsor is rigorously de-identified. 3X Genetics provides information about available therapeutics to clients, but never shares client data with test sponsors or any other person or entity.
Additionally, all health guidance or disease prevalence information generated by the analysis of de-identified client data is shared with our clients and partners at no cost, via online publication.
Supporting Patient Foundations
3X Genetics donates a significant percent of its diagnostic testing revenue to patient foundations.
No Cost Family Tree Testing
Several GRE diseases feature symptom variability, autosomal dominant inheritance (a 50% chance of inheritance) and “anticipation,” which means symptoms increase upon inheritance. Thus, testing the family members of GRE patients is critical!
Being so, 3X Genetics and our sponsors offers FREE TESTING of family members of verified GRE patients. Contact us to learn more.
3X Genetics Inc. 17 Briden Street, Suite 105, Worcester, MA 01605
(c) 3X Genetics Inc. 2024